期刊
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
卷 43, 期 2, 页码 196-201出版社
WILEY
DOI: 10.1111/jcpt.12632
关键词
asphyxia; dosing regimen; neonates; pharmacokinetics; phenobarbital
资金
- Charles University projects Progres [Progres Q25, SVV 260373]
- General University Hospital RV-project [64-165/2012]
What is known and objectivePhenobarbital is the first-line treatment of seizures in asphyxiated neonates; however, due to the high pharmacokinetic variability in this population, there is no consensus on the optimal dosage regimen. This study was conducted to identify variables that affect phenobarbital fate during routine clinical care and then to evaluate the dosage schedule that could be applied in term asphyxiated neonates with respect to achieving the target therapeutic range. MethodsPhenobarbital pharmacokinetics was calculated based on serum concentrations measurements using one-compartmental model. Body weight, body surface area, gestational age, creatinine clearance, total bilirubin, alanine aminotransferase, aspartate aminotransferase, international normalized ratio, Apgar scores, umbilical cord arterial pH and base excess were explored as covariates in linear regression models. Based on this analysis, phenobarbital loading and maintenance dose regimen were projected. Results and discussionIn the whole study population (N=36), phenobarbital volume of distribution, clearance and half-life median (interquartile range) values were 0.49(0.38-0.59)L/kg, 0.0045(0.0034-0.0055)L/h/kg and 75.1(60.2-103.3)hours, respectively. The drug volume of distribution was associated with body weight, length and body surface area, whereas clearance was not in relationship with any explored features. Weight-normalized loading dose of 15mg/kg and weight-normalized daily maintenance dose of 3mg/kg proved to be optimal in our study population to reach phenobarbital therapeutic range. What is new and conclusionsThis study presents basis for phenobarbital initial dosing in term asphyxiated neonates during first week of life. Phenobarbital weight-normalized loading dose of 15mg/kg lead to simulated target peak concentrations in 72% of neonates, weight-normalized maintenance dose of 3mg/kg lead to steady state within therapeutic window in the same proportion of patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据